| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Bordetella pertussis toxin (PT) Antibody (IgG), Immunoassay
Test CodeBPGIA
Alias/See Also
Epic: LAB13985
Pertussis (DTaP) titer
CPT Codes
<p>86615</p>
Preferred Specimen
Specimen Type: Serum
Collection Container/Type
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Minimum Volume
0.25 mL
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Lipemia
Methodology
Immunoassay (IA)
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute, Infectious Disease. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute, Infectious Disease. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Sun, Tues-Fri; Report available: 2-4 days
Report Available
2-4 days
Reference Range
Bordetella pertussis toxin(PT) Ab (IgG), IA
| ≤10 Years | <66 IU/mL |
| 11-59 Years | <43 IU/mL |
| ≥60 Years | <32 IU/mL |
Clinical Significance
Antibody levels above the reference range are highly suggestive of recent infection or vaccination.
Performing Laboratory
Quest Diagnostics Nichols Institute-San Juan Capistrano, CA
33608 Ortega Highway
San Juan Capistrano, CA 92675-2042
Last Updated: March 27, 2023